TSPAN12
Basic information
Region (hg38): 7:120787320-120858402
Previous symbols: [ "TM4SF12" ]
Links
Phenotypes
GenCC
Source:
- exudative vitreoretinopathy 5 (Strong), mode of inheritance: AD
- exudative vitreoretinopathy (Supportive), mode of inheritance: AD
- exudative vitreoretinopathy 5 (Strong), mode of inheritance: AD
- TSPAN12-related vitreoretinopathy (Definitive), mode of inheritance: Semidominant
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Exudative vitreoretinopathy 5; Retinal dysplasia and severe familial exudative vitreoretinopathy | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Ophthalmologic | 20159111; 20159112; 20301326; 21334594; 21552475; 22427576 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (16 variants)
- Exudative vitreoretinopathy 5 (6 variants)
- Familial exudative vitreoretinopathy (1 variants)
- Atrophia bulborum hereditaria (1 variants)
- Persistent hyperplastic primary vitreous, autosomal recessive (1 variants)
- Vitreoretinopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TSPAN12 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 33 | 36 | ||||
missense | 87 | 94 | ||||
nonsense | 6 | |||||
start loss | 1 | |||||
frameshift | 11 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 7 | |||||
splice region | 5 | 7 | 1 | 13 | ||
non coding | 19 | 15 | 22 | 56 | ||
Total | 20 | 8 | 111 | 49 | 26 |
Highest pathogenic variant AF is 0.00000657
Variants in TSPAN12
This is a list of pathogenic ClinVar variants found in the TSPAN12 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-120787322-A-C | Exudative vitreoretinopathy 5 | Benign (Jan 12, 2018) | ||
7-120787349-T-A | Exudative vitreoretinopathy 5 | Benign (Jan 13, 2018) | ||
7-120787352-T-C | Exudative vitreoretinopathy 5 | Uncertain significance (Apr 27, 2017) | ||
7-120787453-T-A | Exudative vitreoretinopathy 5 | Benign (Jan 13, 2018) | ||
7-120787523-CAT-C | Familial exudative vitreoretinopathy | Likely benign (Jun 14, 2016) | ||
7-120787594-C-T | Exudative vitreoretinopathy 5 | Benign (Jan 13, 2018) | ||
7-120787705-G-C | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 13, 2018) | ||
7-120788039-G-C | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 12, 2018) | ||
7-120788258-T-A | Exudative vitreoretinopathy 5 | Benign (Jan 12, 2018) | ||
7-120788263-C-T | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 12, 2018) | ||
7-120788466-A-G | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 12, 2018) | ||
7-120788488-G-T | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 13, 2018) | ||
7-120788489-G-T | Exudative vitreoretinopathy 5 | Uncertain significance (Jan 13, 2018) | ||
7-120788552-A-G | Exudative vitreoretinopathy 5 | Likely benign (Jan 13, 2018) | ||
7-120788553-G-A | Exudative vitreoretinopathy 5 | Benign (Sep 10, 2021) | ||
7-120788593-TA-T | Uncertain significance (Aug 21, 2022) | |||
7-120788597-ACTC-A | Uncertain significance (Aug 10, 2022) | |||
7-120788601-C-T | Likely benign (Aug 24, 2023) | |||
7-120788605-A-C | Uncertain significance (Jan 25, 2024) | |||
7-120788613-G-T | Uncertain significance (May 26, 2022) | |||
7-120788628-G-C | Uncertain significance (Dec 01, 2021) | |||
7-120788633-C-T | Uncertain significance (Nov 21, 2022) | |||
7-120788635-A-G | Inborn genetic diseases | Uncertain significance (Jul 12, 2023) | ||
7-120788635-A-T | Uncertain significance (May 20, 2020) | |||
7-120788640-T-C | Likely benign (Nov 01, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TSPAN12 | protein_coding | protein_coding | ENST00000222747 | 7 | 71081 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.695 | 0.305 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.767 | 131 | 158 | 0.828 | 0.00000742 | 2003 |
Missense in Polyphen | 33 | 44.737 | 0.73764 | 563 | ||
Synonymous | -0.0435 | 56 | 55.6 | 1.01 | 0.00000268 | 564 |
Loss of Function | 3.14 | 3 | 17.0 | 0.177 | 7.24e-7 | 210 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000301 | 0.000300 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000264 | 0.0000264 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of cell surface receptor signal transduction. Plays a central role in retinal vascularization by regulating norrin (NDP) signal transduction. Acts in concert with norrin (NDP) to promote FZD4 multimerization and subsequent activation of FZD4, leading to promote accumulation of beta-catenin (CTNNB1) and stimulate LEF/TCF-mediated transcriptional programs. Suprisingly, it only activate the norrin (NDP)-dependent activation of FZD4, while it does not activate the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1) (By similarity). Acts as a regulator of membrane proteinases such as ADAM10 and MMP14/MT1-MMP. Activates ADAM10-dependent cleavage activity of amyloid precursor protein (APP). Activates MMP14/MT1-MMP-dependent cleavage activity. {ECO:0000250, ECO:0000269|PubMed:19211836, ECO:0000269|PubMed:19587294}.;
- Disease
- DISEASE: Vitreoretinopathy, exudative 5 (EVR5) [MIM:613310]: A disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery. {ECO:0000269|PubMed:20159111, ECO:0000269|PubMed:20159112, ECO:0000269|PubMed:22427576}. Note=The disease is caused by mutations affecting the gene represented in this entry. TSPAN12 dominant and recessive mutations have been identified in patients with exudative vitreoretinopathy. Patients with mutations in both alleles of TSPAN12 have severe exudative vitreoretinopathy or retinal dysplasia. These mutations appear to result in a milder phenotype in heterozygous mutation carriers (PubMed:22427576). {ECO:0000269|PubMed:22427576}.;
Recessive Scores
- pRec
- 0.0790
Intolerance Scores
- loftool
- 0.456
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.64
Haploinsufficiency Scores
- pHI
- 0.500
- hipred
- Y
- hipred_score
- 0.644
- ghis
- 0.522
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.398
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tspan12
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- angiogenesis;cell surface receptor signaling pathway;retina layer formation;Wnt signaling pathway;regulation of angiogenesis
- Cellular component
- integral component of plasma membrane;membrane;integral component of membrane
- Molecular function
- protein binding;Wnt-activated receptor activity